These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28292939)

  • 1. A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.
    Chien MH; Chang WM; Lee WJ; Chang YC; Lai TC; Chan DV; Sharma R; Lin YF; Hsiao M
    Mol Cancer Ther; 2017 Jun; 16(6):1102-1113. PubMed ID: 28292939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of FasL expression in oral squamous cell cancer.
    Fang L; Sun L; Hu FF; Chen QE
    Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ADAM10, Fas, FasL and Soluble FasL in Patients with Oral Squamous Cell Carcinoma (OSCC) and their Association with Clinical-Pathological Parameters.
    Zepeda-Nuño JS; Guerrero-Velázquez C; Del Toro-Arreola S; Vega-Magaña N; Ángeles-Sánchez J; Haramati J; Pereira-Suárez AL; Bueno-Topete MR
    Pathol Oncol Res; 2017 Apr; 23(2):345-353. PubMed ID: 27628319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.
    Das SN; Khare P; Singh MK; Sharma SC
    Indian J Med Res; 2011 Jul; 134(1):54-60. PubMed ID: 21808135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAS/FASL expression profile as a prognostic marker in squamous cell carcinoma of the oral cavity.
    de Carvalho-Neto PB; dos Santos M; de Carvalho MB; Mercante AM; dos Santos VP; Severino P; Tajara EH; Louro ID; da Silva-Conforti AM
    PLoS One; 2013; 8(7):e69024. PubMed ID: 23894399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma.
    Loro LL; Vintermyr OK; Johannessen AC; Liavaag PG; Jonsson R
    J Oral Pathol Med; 1999 Feb; 28(2):82-7. PubMed ID: 9950255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma.
    Cai Y; Wang F; Liu Q; Li Z; Li D; Sun Z
    Invest New Drugs; 2019 Oct; 37(5):799-809. PubMed ID: 30368626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.
    Kaneko MK; Nakamura T; Kunita A; Fukayama M; Abe S; Nishioka Y; Yamada S; Yanaka M; Saidoh N; Yoshida K; Fujii Y; Ogasawara S; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):104-112. PubMed ID: 28504613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAS ligand expression in inflammatory infiltrate lymphoid cells as a prognostic marker in oral squamous cell carcinoma.
    Peterle GT; Santos M; Mendes SO; Carvalho-Neto PB; Maia LL; Stur E; Agostini LP; Silva CV; Trivilin LO; Nunes FD; Carvalho MB; Tajara EH; Louro ID; Silva-Conforti AM
    Genet Mol Res; 2015 Sep; 14(3):11145-53. PubMed ID: 26400345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of fas (CD95) ligand is correlated with IL-10 and granulocyte colony-stimulating factor expression in oral and oropharyngeal squamous cell carcinoma.
    Fujieda S; Sunaga H; Tsuzuki H; Fan GK; Ito T; Sugimoto C; Saito H
    Cancer Lett; 2000 Dec; 161(1):73-81. PubMed ID: 11078915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
    Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
    Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
    Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD95 (Fas) ligand-expressing vesicles display antibody-mediated, FcR-dependent enhancement of cytotoxicity.
    Jodo S; Hohlbaum AM; Xiao S; Chan D; Strehlow D; Sherr DH; Marshak-Rothstein A; Ju ST
    J Immunol; 2000 Nov; 165(10):5487-94. PubMed ID: 11067901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy.
    Ravindranath NM; Nishimoto K; Chu K; Shuler C
    Anticancer Res; 2000; 20(1A):21-6. PubMed ID: 10769630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer.
    Nagai K; Nakahata S; Shimosaki S; Tamura T; Kondo Y; Baba T; Taki T; Taniwaki M; Kurosawa G; Sudo Y; Okada S; Sakoda S; Morishita K
    Cancer Med; 2014 Aug; 3(4):1085-99. PubMed ID: 24890018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis.
    Rigberg DA; Centeno J; Kim FS; Ke B; Swenson K; Maggard M; McFadden DW
    J Surg Oncol; 1999 Jun; 71(2):91-6. PubMed ID: 10389864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for the Fas-/Fas-Ligand pathway in chemoresistance of human squamous cell carcinomas of the head and neck (SCCHN)?
    Sproll KC; Balló H; Hoffmann TK; Scheckenbach K; Koldovsky U; Balz V; Hafner D; Ramp U; Bier H
    Oral Oncol; 2009 Jan; 45(1):69-84. PubMed ID: 18620901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Slit-Robo signal on apoptosis of oral cancer cell line Tb].
    Ma YG; Wang LJ; Han B; Zhang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Apr; 41(4):232-5. PubMed ID: 16784591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.